Your browser doesn't support javascript.
loading
Lung Organoids-The Ultimate Tool to Dissect Pulmonary Diseases?
Bosáková, Veronika; De Zuani, Marco; Sládková, Lucie; Garlíková, Zuzana; Jose, Shyam Sushama; Zelante, Teresa; Hortová Kohoutková, Marcela; Fric, Jan.
Afiliación
  • Bosáková V; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
  • De Zuani M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia.
  • Sládková L; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
  • Garlíková Z; Institute of Hematology and Blood Transfusion, Prague, Czechia.
  • Jose SS; Department of Cell Biology, Faculty of Science, Charles University, Prague, Czechia.
  • Zelante T; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
  • Hortová Kohoutková M; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia.
  • Fric J; Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Front Cell Dev Biol ; 10: 899368, 2022.
Article en En | MEDLINE | ID: mdl-35912110
ABSTRACT
Organoids are complex multicellular three-dimensional (3D) in vitro models that are designed to allow accurate studies of the molecular processes and pathologies of human organs. Organoids can be derived from a variety of cell types, such as human primary progenitor cells, pluripotent stem cells, or tumor-derived cells and can be co-cultured with immune or microbial cells to further mimic the tissue niche. Here, we focus on the development of 3D lung organoids and their use as disease models and drug screening tools. We introduce the various experimental approaches used to model complex human diseases and analyze their advantages and disadvantages. We also discuss validation of the organoids and their physiological relevance to the study of lung diseases. Furthermore, we summarize the current use of lung organoids as models of host-pathogen interactions and human lung diseases such as cystic fibrosis, chronic obstructive pulmonary disease, or SARS-CoV-2 infection. Moreover, we discuss the use of lung organoids derived from tumor cells as lung cancer models and their application in personalized cancer medicine research. Finally, we outline the future of research in the field of human induced pluripotent stem cell-derived organoids.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article